These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11827799)

  • 21. Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.
    Schein CH; Chen D; Ma L; Kanalas JJ; Gao J; Jimenez ME; Sower LE; Walter MA; Gilbertson SR; Peterson JW
    Toxins (Basel); 2012 Nov; 4(11):1288-300. PubMed ID: 23202316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural biology: anthrax hijacks host receptor.
    Bann JG; Hultgren SJ
    Nature; 2004 Aug; 430(7002):843-4. PubMed ID: 15318206
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.
    Johnson SL; Chen LH; Barile E; Emdadi A; Sabet M; Yuan H; Wei J; Guiney D; Pellecchia M
    Bioorg Med Chem; 2009 May; 17(9):3352-68. PubMed ID: 19359184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
    Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. War against anthrax.
    Khanna H; Singh Y
    Mol Med; 2001 Dec; 7(12):795-6. PubMed ID: 11844866
    [No Abstract]   [Full Text] [Related]  

  • 27. Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.
    Johnson SL; Jung D; Forino M; Chen Y; Satterthwait A; Rozanov DV; Strongin AY; Pellecchia M
    J Med Chem; 2006 Jan; 49(1):27-30. PubMed ID: 16392787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the anti-toxin abilities of the CMG2-Fc fusion protein with the aid of computational design.
    Xi Y; Wu X; Gao L; Shao Y; Peng H; Chen H; Chen H; Hu X; Yue J
    PLoS One; 2014; 9(8):e104674. PubMed ID: 25101992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the cellular receptor for anthrax toxin.
    Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
    Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthrax Pathogenesis.
    Moayeri M; Leppla SH; Vrentas C; Pomerantsev AP; Liu S
    Annu Rev Microbiol; 2015; 69():185-208. PubMed ID: 26195305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.
    Jiao GS; Cregar L; Goldman ME; Millis SZ; Tang C
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1527-31. PubMed ID: 16386899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How anthrax kills.
    Hanna P
    Science; 1998 Jun; 280(5370):1671, 1673-4. PubMed ID: 9660700
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitors of Bacillus anthracis edema factor.
    Seifert R; Dove S
    Pharmacol Ther; 2013 Nov; 140(2):200-12. PubMed ID: 23850654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening inhibitors of anthrax lethal factor.
    Tonello F; Seveso M; Marin O; Mock M; Montecucco C
    Nature; 2002 Jul; 418(6896):386. PubMed ID: 12140548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
    Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
    Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of anthrax toxin in pathogenesis.
    Moayeri M; Leppla SH
    Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Certhrax toxin, an anthrax-related ADP-ribosyltransferase from Bacillus cereus.
    Visschedyk D; Rochon A; Tempel W; Dimov S; Park HW; Merrill AR
    J Biol Chem; 2012 Nov; 287(49):41089-102. PubMed ID: 22992735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptors of anthrax toxin and cell entry.
    van der Goot G; Young JA
    Mol Aspects Med; 2009 Dec; 30(6):406-12. PubMed ID: 19732789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.
    Zhang X; Amin EA
    J Mol Graph Model; 2016 Jan; 63():22-8. PubMed ID: 26615468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthrax toxin: a tripartite lethal combination.
    Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
    FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.